1. Radford, D.M., Phillips, N.J., Fair, K.L., Ritter, J.H., Holt, M., and Donis-Keller, H. (1995). Allelic loss and the progression of breast cancer.(erratum appears in Cancer Res 1996 Feb 15;56(4):935). Cancer Research. 55, 5180–5183.
2. Brenner, A.J., and Aldaz, C.M. (1997). The genetics of sporadic breast cancer. In Etology of breast and gynecological cancers, C.M. Aldaz, M.N. Gould, J. Mclauchlan and J. Slaga, eds. (New York, NY: Wiley-Liss), pp. 63–82.
3. Jensen, R.A., Dupont, W.D., and Page, D.L. (1993). Diagnostic criteria and cancer risk of proliferative breast lesions. Journal of Cellular Biochemistry — Supplement. 17G, 59–64.
4. Marshall, L.M., Hunter, D.J., Connolly, J.L., Schnitt, S.J., Byrne, C., London, S.J., and Colditz, G.A. (1997). Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiology, Biomarkers & Prevention. 6, 297–301.
5. Couch, F.J., and Weber, B.L. (1998). Breast cancer. In The genetic basis of human cancer, B. Vogelstein and K.W. Kinzler, eds. (New York, NY: McGraw Hill), pp. 537–563.